Cefixime Dosing
For adults, administer cefixime 400 mg once daily; for children ≥6 months, give 8 mg/kg/day as a single dose or divided every 12 hours; in moderate renal impairment (CrCl 21–59 mL/min), reduce the adult dose to approximately 260 mg daily (13 mL of 100 mg/5 mL suspension or 6.5 mL of 200 mg/5 mL suspension). 1
Adult Dosing (Normal Renal Function)
- The standard adult dose is 400 mg daily, administered as a single 400 mg capsule. 1
- Cefixime may be taken without regard to food, as food does not significantly affect absorption. 1
- For uncomplicated cervical/urethral gonococcal infections, a single oral dose of 400 mg is recommended. 1
Pediatric Dosing (≥6 Months of Age)
- The recommended dose is 8 mg/kg/day of the oral suspension. 1
- This may be given as a single daily dose or divided into 4 mg/kg every 12 hours. 1
- Children weighing >45 kg or >12 years should receive the standard adult dose of 400 mg daily. 1
Important Pediatric Considerations
- Otitis media must be treated with the suspension formulation, not tablets or capsules, because the suspension achieves higher peak blood levels at equivalent doses. 1
- Always specify the concentration when prescribing in milliliters, as cefixime suspension is available in two concentrations: 100 mg/5 mL and 200 mg/5 mL. 1
Renal Impairment Dosing (Adults)
- Normal dosing (400 mg daily) is appropriate for patients with creatinine clearance ≥60 mL/min. 1
Moderate Renal Impairment (CrCl 21–59 mL/min)
- Reduce dose to 13 mL of 100 mg/5 mL suspension (260 mg) or 6.5 mL of 200 mg/5 mL suspension (260 mg) once daily. 1
- The 200 mg/5 mL concentration is preferred for patients with renal dysfunction. 1
- This dosing also applies to patients on hemodialysis. 1
Severe Renal Impairment (CrCl ≤20 mL/min)
- Reduce dose to 8.6 mL of 100 mg/5 mL suspension (172 mg) or 4.4 mL of 200 mg/5 mL suspension (176 mg) once daily. 1
- This dosing also applies to patients on continuous peritoneal dialysis. 1
Key Renal Dosing Principles
- Neither hemodialysis nor peritoneal dialysis removes significant amounts of cefixime from the body, so supplemental post-dialysis doses are not needed. 1, 2
- The elimination half-life increases from approximately 3–4 hours in normal renal function to 12–14 hours in patients with CrCl <20 mL/min. 3, 2
- Pharmacokinetic alterations become statistically significant when creatinine clearance falls below 20 mL/min. 2
Duration of Therapy
- For infections caused by Streptococcus pyogenes, administer cefixime for at least 10 days to prevent complications such as acute rheumatic fever. 1
- For most other indications, a median therapy duration of 6 days has demonstrated high efficacy (98.7% cure/improvement in adults, 98.0% in children). 4
Clinical Efficacy Evidence
- Large post-marketing surveillance (9,568 patients) demonstrated cure or improvement in 98.7% of adults and 98.0% of children with respiratory tract infections. 4
- Multinational studies confirm excellent microbiological eradication, including 100% of Streptococcus pneumoniae isolates from children and 89% of isolates from adults with respiratory infections. 5
- Adverse events occur in only 1.12% of adults and 1.92% of children, with 96.7% of children accepting the dry syrup formulation very well or well. 4
Common Pitfalls to Avoid
- Do not substitute tablets/capsules for suspension when treating otitis media in children, as bioavailability differs significantly. 1
- Always verify suspension concentration (100 mg/5 mL vs. 200 mg/5 mL) when prescribing volume-based doses to prevent dosing errors. 1
- Do not use normal doses in patients with CrCl <60 mL/min without appropriate dose reduction, as drug accumulation occurs. 1, 3
- Reconstituted suspension remains stable for only 14 days at room temperature or refrigerated; discard unused portions after this period. 1